Literature DB >> 6214431

Potential new treatment of endometriosis: reversible inhibition of pituitary-ovarian function by chronic intranasal administration of a luteinizing hormone-releasing hormone (LH-RH) agonist.

A Lemay, G Quesnel.   

Abstract

Entities:  

Keywords:  Biology; Case Studies; Endocrine System; Endometrial Effects; Endometrium; Genitalia; Genitalia, Female; Gonadotropins; Hormones; Physiology; Pituitary Hormone Releasing Hormones; Research Methodology; Studies; Treatment; Urogenital System; Uterus

Mesh：

Substances：

Year:  1982        PMID： 6214431     DOI： 10.1016/s0015-0282(16)46522-2

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


× No keyword cloud information.
  8 in total

Review 1.  Buserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical profile.

Authors:  R N Brogden; M M Buckley; A Ward
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

2.  Sustained pharmacological activities in rats following single and repeated administration of once-a-month injectable microspheres of leuprolide acetate.

Authors:  H Okada; T Heya; Y Ogawa; H Toguchi; T Shimamoto
Journal:  Pharm Res       Date:  1991-05       Impact factor: 4.200

Review 3.  Luteinizing hormone-releasing hormone and its analogues: a review of biological properties and clinical uses.

Authors:  B J Furr; J R Woodburn
Journal:  J Endocrinol Invest       Date:  1988 Jul-Aug       Impact factor: 4.256

4.  Influence of experimental rhinitis on the gonadotropin response to intranasal administration of buserelin.

Authors:  C Larsen; M Niebuhr Jørgensen; B Tommerup; N Mygind; E E Dagrosa; H G Grigoleit; V Malerczyk
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 5.  GnRH and its analogues. Current therapeutic applications and new prospects.

Authors:  H M Fraser
Journal:  Drugs       Date:  1984-03       Impact factor: 9.546

6.  Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis.

Authors:  R W Shaw; H M Fraser; H Boyle
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-03

7.  Sustained activity and release of leuprolide acetate from an in situ forming polymeric implant.

Authors:  H B Ravivarapu; K L Moyer; R L Dunn
Journal:  AAPS PharmSciTech       Date:  2000-02-28       Impact factor: 3.246

Review 8.  GnRH agonists and antagonists. Current clinical status.

Authors:  M Filicori; C Flamigni
Journal:  Drugs       Date:  1988-01       Impact factor: 9.546
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.